Factors Associated with Complete Remission after Rituximab Therapy for Pemphigus
© 2019 American Medical Association. All rights reserved. Importance: Rituximab has emerged as a front-line therapy for pemphigus, but prognostic factors for achieving complete remission off therapy (CROT) with oral systemic agents remain unknown. Objectives: To describe rates of CROT and relapse an...
Saved in:
Main Authors: | Carolyn J. Kushner, Shiyu Wang, Napatra Tovanabutra, Donald E. Tsai, Victoria P. Werth, Aimee S. Payne |
---|---|
Format: | Journal |
Published: |
2020
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85074187164&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/67936 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Clinical outcome and safety of rituximab therapy for pemphigoid diseases
by: Napatra Tovanabutra, et al.
Published: (2020) -
Rituximab therapy for treatment of pemphigus in Southeast Asians
by: Silada Kanokrungsee, et al.
Published: (2022) -
Rituximab treatment for paraneoplastic pemphigus associated with follicular B-cell lymphoma: A case report and review of treatment outcome
by: Waranaree Winayanuwattikun, et al.
Published: (2019) -
Rituximab-induced psoriasis in a patient with pemphigus foliaceous: A case report and literature review
by: Norramon Charoenpipatsin, et al.
Published: (2022) -
Rituximab-induced psoriasis in a patient with pemphigus foliaceous: A case report and literature review
by: Charoenpipatsin N.
Published: (2023)